Onychomycosis is a fungal infection of the fingernails or toenails. The actual infection is of the bed of the nail and of the plate under the surface of the nail.
Onychomycosis is the most common of all diseases of the nails in adults. In North America, the incidence falls roughly between 2–13%. The incidence of onychomycosis is also greater in older adults, and up to 90% of the elderly may be affected. Men are more commonly infected than women.
Individuals who are especially susceptible include those with chronic diseases such as diabetes and circulatory problems and those with diseases that suppress the immune system. Other risk factors include a family history, previous trauma to the nails, warm climate, occlusive or tight footwear.
Onychomycosis is caused by three types of fungi, called dermatophytes, yeasts, and nondermatophyte molds. Fungi are simple parasitic plant organisms that don't need sunlight to grow. Toenails are especially susceptible because fungi prefer dark damp places. Swimming pools, locker rooms, and showers typically harbor fungi. Chronic diseases such as diabetes, problems with the circulatory system, or immune deficiency disease are risk factors. A history of athlete's foot and excess perspiration are also risk factors.
Onychomycosis can be present for years without causing pain or disturbing symptoms. Typically, the nail becomes thicker and changes to a yellowish-brown. Foul smelling debris may collect under the nail. The infection can spread to the surrounding nails and even the skin.
To make a diagnosis of onychomycosis, the clinician must collect a specimen of the nail in which infection is suspected. A clipping is taken from the nail plate, and a sample of the debris from underneath the nail bed is also taken, usually with a sharp curette. Debris from the nail surface may also be taken. These will be sent for microscopic analysis to a laboratory, as well as cultured to determine what types of fungus are growing there.
Onychomycosis is very difficult and sometimes impossible to treat, and therapy is often long-term. Therapy consists of topical treatments that are applied directly to the nails, as well as two systemic drugs, griseofulvin and ketoconazole. Topical therapy is reserved for only the mildest cases. The use of griseofulvin and ketoconazole is problematic, and there are typically high relapse rates of 50–85%. In addition, treatment must be continued for a
In the past few years, newer oral antifungal agents have been developed, and include itraconazole (Sporanox), terbinafine (Lamisil), and fluconazole (Diflucan). These agents, when taken orally for as little as 12 weeks, bring about better cure rates and fewer side effects than either griseofulvin or ketoconazole. The most common side effect is stomach upset. Patients taking oral antifungal therapy must have a complete blood count and liver enzyme workup every four to six weeks. Terbinafine in particular has markedly less toxicity to the liver, one of the more severe side effects of the older agents, griseofulvin and ketoconazole.
Treatment should be continued until microscopic exam or culture shows no more fungal infection. Nails may, however, continue to look damaged even after a clinical cure is achieved. Nails may take up to a full year to return to normal. If the nail growth slows or stops, additional doses of antifungal therapy should be taken.
Nail debridement is another treatment option, but it is considered by many to be primitive compared with topical or systemic treatment. Clinicians perform nail debridement in their offices. The nail is cut and then thinned using surgical tools or chemicals, and then the loose debris under the nail is removed. The procedure is painless, and often improves the appearance of the nails immediately. In addition, it helps whatever medication being used to penetrate the newly thinned nail. Patients with very thickened nails will sometimes undergo chemical removal of a nail. A combination of oral, topical, and surgical removal can increase the chances of curing the infection.
|
|
Author Info: Liz Meszaros, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Medicine, 2002 |